A detailed history of Torren Management, LLC transactions in Reneo Pharmaceuticals, Inc. stock. As of the latest transaction made, Torren Management, LLC holds 504 shares of RPHM stock, worth $846. This represents 0.0% of its overall portfolio holdings.

Number of Shares
504
Holding current value
$846
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 29, 2026

BUY
N/A
504 New
504 $1.46 Million

Others Institutions Holding RPHM

About Reneo Pharmaceuticals, Inc.


  • Ticker RPHM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,479,600
  • Market Cap $41.1M
  • Description
  • Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development of therapies for patients with rare genetic mitochondrial diseases. It develops REN001, a selective peroxisome proliferator-activated receptor delta agonist, which is in Phase IIb clinical trial in patients with primary mitochondrial myopathies, as w...
More about RPHM
Track This Portfolio

Track Torren Management, LLC Portfolio

Follow Torren Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Torren Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Torren Management, LLC with notifications on news.